1. Home
  2. OLMA vs VEON Comparison

OLMA vs VEON Comparison

Compare OLMA & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • VEON
  • Stock Information
  • Founded
  • OLMA 2006
  • VEON 1992
  • Country
  • OLMA United States
  • VEON Netherlands
  • Employees
  • OLMA N/A
  • VEON N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • VEON Telecommunications Equipment
  • Sector
  • OLMA Health Care
  • VEON Telecommunications
  • Exchange
  • OLMA Nasdaq
  • VEON Nasdaq
  • Market Cap
  • OLMA 465.4M
  • VEON 2.4B
  • IPO Year
  • OLMA 2020
  • VEON 1996
  • Fundamental
  • Price
  • OLMA $6.10
  • VEON $39.04
  • Analyst Decision
  • OLMA Strong Buy
  • VEON Strong Buy
  • Analyst Count
  • OLMA 5
  • VEON 1
  • Target Price
  • OLMA $26.25
  • VEON $48.00
  • AVG Volume (30 Days)
  • OLMA 1.1M
  • VEON 75.3K
  • Earning Date
  • OLMA 11-12-2024
  • VEON 11-14-2024
  • Dividend Yield
  • OLMA N/A
  • VEON N/A
  • EPS Growth
  • OLMA N/A
  • VEON N/A
  • EPS
  • OLMA N/A
  • VEON N/A
  • Revenue
  • OLMA N/A
  • VEON $3,955,000,000.00
  • Revenue This Year
  • OLMA N/A
  • VEON $12.10
  • Revenue Next Year
  • OLMA N/A
  • VEON $7.27
  • P/E Ratio
  • OLMA N/A
  • VEON $4.35
  • Revenue Growth
  • OLMA N/A
  • VEON 7.36
  • 52 Week Low
  • OLMA $5.56
  • VEON $18.50
  • 52 Week High
  • OLMA $16.78
  • VEON $39.87
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 27.05
  • VEON 74.32
  • Support Level
  • OLMA $5.56
  • VEON $34.87
  • Resistance Level
  • OLMA $6.87
  • VEON $36.86
  • Average True Range (ATR)
  • OLMA 0.81
  • VEON 1.49
  • MACD
  • OLMA -0.28
  • VEON 0.23
  • Stochastic Oscillator
  • OLMA 10.12
  • VEON 86.28

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About VEON VEON Ltd. ADS

VEON Ltd is a global provider of connectivity and internet services. The company provides its customers with voice, fixed broadband, data, and digital services. Currently, the company offers services to customers in the following countries: Pakistan, Ukraine, Kazakhstan, Bangladesh, Uzbekistan, and Kyrgyzstan. The reportable segments currently consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. The company provides services under the Beeline, Kyivstar, banglalink and Jazz brands.

Share on Social Networks: